245 related articles for article (PubMed ID: 10480403)
1. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism.
Spitzer TR; Delmonico F; Tolkoff-Rubin N; McAfee S; Sackstein R; Saidman S; Colby C; Sykes M; Sachs DH; Cosimi AB
Transplantation; 1999 Aug; 68(4):480-4. PubMed ID: 10480403
[TBL] [Abstract][Full Text] [Related]
2. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease.
Bühler LH; Spitzer TR; Sykes M; Sachs DH; Delmonico FL; Tolkoff-Rubin N; Saidman SL; Sackstein R; McAfee S; Dey B; Colby C; Cosimi AB
Transplantation; 2002 Nov; 74(10):1405-9. PubMed ID: 12451240
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease.
Spitzer TR; Sykes M; Tolkoff-Rubin N; Kawai T; McAfee SL; Dey BR; Ballen K; Delmonico F; Saidman S; Sachs DH; Cosimi AB
Transplantation; 2011 Mar; 91(6):672-6. PubMed ID: 21217460
[TBL] [Abstract][Full Text] [Related]
4. Twenty-year Follow-up of Histocompatibility Leukocyte Antigen-matched Kidney and Bone Marrow Cotransplantation for Multiple Myeloma With End-stage Renal Disease: Lessons Learned.
Spitzer TR; Tolkoff-Rubin N; Cosimi AB; McAfee S; Dey BR; Chen YB; Delmonico F; Sykes M; Sachs DH; Kawai T
Transplantation; 2019 Nov; 103(11):2366-2372. PubMed ID: 30801529
[TBL] [Abstract][Full Text] [Related]
5. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.
Spitzer TR; McAfee S; Sackstein R; Colby C; Toh HC; Multani P; Saidman S; Weyouth DW; Preffer F; Poliquin C; Foley A; Cox B; Andrews D; Sachs DH; Sykes M
Biol Blood Marrow Transplant; 2000; 6(3A):309-20. PubMed ID: 10905768
[TBL] [Abstract][Full Text] [Related]
6. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.
Fudaba Y; Spitzer TR; Shaffer J; Kawai T; Fehr T; Delmonico F; Preffer F; Tolkoff-Rubin N; Dey BR; Saidman SL; Kraus A; Bonnefoix T; McAfee S; Power K; Kattleman K; Colvin RB; Sachs DH; Cosimi AB; Sykes M
Am J Transplant; 2006 Sep; 6(9):2121-33. PubMed ID: 16796719
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.
Trivedi HL; Vanikar AV; Modi PR; Shah VR; Vakil JM; Trivedi VB; Khemchandani SI
Transplant Proc; 2005 Mar; 37(2):737-42. PubMed ID: 15848518
[TBL] [Abstract][Full Text] [Related]
8. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
9. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of renal failure caused by multiple myeloma with HLA-identical living kidney and bone marrow transplantation: a case report.
Wagner L; Lengyel L; Mikala G; Reményi P; Piros L; Csomor J; Fábry L; Tordai A; Langer RM; Masszi T
Transplant Proc; 2013; 45(10):3705-7. PubMed ID: 24315003
[TBL] [Abstract][Full Text] [Related]
11. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys.
Kawai T; Cosimi AB; Wee SL; Houser S; Andrews D; Sogawa H; Phelan J; Boskovic S; Nadazdin O; Abrahamian G; Colvin RB; Sach DH; Madsen JC
Transplantation; 2002 Jun; 73(11):1757-64. PubMed ID: 12084998
[TBL] [Abstract][Full Text] [Related]
12. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance.
Kawai T; Poncelet A; Sachs DH; Mauiyyedi S; Boskovic S; Wee SL; Ko DS; Bartholomew A; Kimikawa M; Hong HZ; Abrahamian G; Colvin RB; Cosimi AB
Transplantation; 1999 Dec; 68(11):1767-75. PubMed ID: 10609955
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
[TBL] [Abstract][Full Text] [Related]
16. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Sachs DH; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
18. Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.
Oura T; Ko DS; Boskovic S; O'Neil JJ; Chipashvili V; Koulmanda M; Hotta K; Kawai K; Nadazdin O; Smith RN; Cosimi AB; Kawai T
Cell Transplant; 2016; 25(7):1331-41. PubMed ID: 26337731
[TBL] [Abstract][Full Text] [Related]
19. Inducing Transient Mixed Chimerism for Allograft Survival Without Maintenance Immunosuppression With Combined Kidney and Bone Marrow Transplantation: Protocol Optimization.
Lee KW; Park JB; Park H; Kwon Y; Lee JS; Kim KS; Chung YJ; Rhu JS; Choi S; Kwon GY; Kim HJ; Kang ES; Jung CW; Shin EC; Kawai T; Kim SJ; Joh JW
Transplantation; 2020 Jul; 104(7):1472-1482. PubMed ID: 31634324
[TBL] [Abstract][Full Text] [Related]
20. Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism.
Kawai T; Cosimi AB; Sachs DH
Curr Opin Organ Transplant; 2011 Aug; 16(4):366-71. PubMed ID: 21666482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
